Rappel de cobas 6800 system - cobas MPX, 96 tests and cobas MPX, 480 tests. An in-vitro diagnostic medical device (IVD). cobas MPX, 96 tests

Selon Department of Health, Therapeutic Goods Administration, ce/cet/cette rappel concerne un dispositif en/au/aux/à Australia qui a été fabriqué par Roche Diagnostics Australia Pty Limited.

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
    Recall
  • ID de l'événement
    RC-2016-RN-00833-1
  • Classe de risque de l'événement
    Class I
  • Date de mise en oeuvre de l'événement
    2016-06-27
  • Pays de l'événement
  • Source de l'événement
    DHTGA
  • URL de la source de l'événement
  • Notes / Alertes
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Notes supplémentaires dans les données
  • Cause
    Roche diagnostics australia is informing users that in extremely rare cases, sample under-aspiration may occur when using the cobas 6800 system with sample input volumes of less than 450 µl. this issue will only affect the cobas mpx test when used with cadaveric donors, since the minimum sample volume required for cadaveric donors is 300 µl (for living donors, the minimum sample volume required is 1,000 µl).If bubbles or foam are present in the sample tube, this may lead to false sample liquid level detection and under-aspiration of the sample. this could potentially cause false negative / under-quantitated results that are not flagged.
  • Action
    Roche is advising users to ensure good sample preparation technique to avoid the formation of foam, clots, or bubbles in all samples, as described within the instrument safety manual. A look-back at previous cadaveric results is also recommended. Roche will be implementing a software correction as a permanent fix..

Device

  • Modèle / numéro de série
    cobas 6800 system - cobas MPX, 96 tests and cobas MPX, 480 tests. An in-vitro diagnostic medical device (IVD). cobas MPX, 96 testsMaterial Number: 06997708190All Lot Numbers affectedcobas MPX, 480 testsMaterial Number: 06997716190All Lot Numbers affectedARTG Number: 275469
  • Manufacturer

Manufacturer